Myotonic dystrophy is an inherited multi-system disease. Its pathophysiology leading to muscle malfunction and damage is not well understood. 23Na NMR spectroscopy was applied here for an in vivo comparative study of the calf muscles of 7 myotonic dystrophy patients at various stages of the disease and 11 healthy volunteers. Both the total sodium content, expressed as the ratio of the 23Na and 1H water signals, and the fast transverse relaxation time, T21, determined from the triple quantum-filtered spectra, increased in correlation with the severity of the disease. The results demonstrate that 23Na NMR enables the quantitation of myotonic dystrophy progression. 相似文献
Malignant thymomas are among the least common mediastinal tumors in the pediatric age group. Thymomas are considered malignant on the basis of macroscopic and microscopic invasiveness. As only 20 well-documented cases involving children have been reported in the literature, the pattern of responsiveness to therapy and the value of prognostic signs is obscure. Two cases of malignant pediatric thymomas are reported with pathognomonic histoimmunological features of aggressive thymoma. One was cured, with a follow-up of 70 months, and one died while on therapy. Analysis of the histological features and the immunoperoxidase staining displays the complexity of pediatric thymomas and the inability to prognosticate the outcome, respectively. 相似文献
ABSTRACT This study used data collected by Statistics Canada in the Mental Health and Well-being cycle of the Canadian Community Health Survey (N = 20,211) to examine the associations between disordered eating behavior and selected mood, anxiety and substance use disorders in adult women grouped in three age groups. Significant associations between disordered eating behaviors and major depression, substance dependence and psychological distress were found for women in all three age ranges. Prevalence of specific classes of anxiety disorders in women who reported disordered eating behaviors differed according to their age. Having disordered eating behaviors was significantly associated with both 12-month and lifetime prevalence of social phobia for women above 25 years of age. Lifetime prevalence of agoraphobia was associated with disordered eating behaviors in women 15–44 years old, and the 12-month prevalence was associated with disordered eating behaviors only in women 15–24 years of age. Disordered eating behaviors were significantly associated with lifetime prevalence of panic disorder in women in all three age ranges and with 12-month prevalence of panic disorder in women in two age ranges, 15–24 and 45 and above. The findings highlight the importance of taking age into consideration when developing assessment instruments and treatment strategies to address the co-occurrence of eating disorders and other psychiatric disorders. 相似文献
Introduction: Since 2010 some evidence supporting the possible increased cardiovascular (CV) risk related to testosterone treatment (TTh) has created much debate in the scientific community. Based on these results, the US Food and Drug Administration agency has questioned TTh for aging men recognizing its value only for classical hypogonadism due to genetic or organic causes. To better clarify this topic, we scrutinized and summarized, also by using meta-analytic methods, the data generated during the last 7 years, as derived from the analysis of randomized controlled trials (RCTs) on TTh and CV risk.
Areas covered: Analysis included 31 RCTs published between 2010 and 2018. Retrieved trials included 2675 and 2308 patients in TTh and placebo groups, respectively. The analysis documented that TTh was not associated with an increased CV mortality or morbidity either when overall or major adverse CV events were considered.
Expert commentary: Despite present evidence it is important to recognize that the duration of the available trials is short (lower that 3 years) limiting final conclusions on this topic. In particular, the available information on possible long-term effects of TTh on CV risk is limited. Long-term safety studies are advisable to better clarify these points. 相似文献
ABSTRACTUsing data from a community-based sample (Project EAT-III), this study (N = 1241; mean age = 25.2) examined the relationship of feminist identity with body image and disordered eating. Feminist-identified women reported significantly higher body satisfaction than non-feminist women and women who did not identify as feminists but held feminist beliefs. However, feminist-identified women did not differ from non-feminist women in disordered eating. Women holding feminist beliefs and non-feminist women did not differ in body satisfaction. Our findings suggest that self-identification as a feminist may promote positive body image in young adult women, but may be insufficient to change behaviors. 相似文献
Neurological Sciences - Bradykinesia, dysrhythmia, and decrement in hand movements (HM) are core symptoms of Parkinson’s disease (PD). The maximal rate of repetitive rhythm-preserving HM can... 相似文献
Higher-level gait disorder (HLGD) in older adults is characterized by postural instability, stepping dysrhythmicity, recurrent falls and progressive immobility. Cognitive impairments are frequently associated with HLGD.
Objectives
The aim of this study was to compare gait and cognitive performance before and after the use of rivastigmine in patients with HLGD, free from cognitive impairment or Parkinsonism.
Methods
Fifteen non-demented patients with HLGD (age 79.2 ± 5.9 years; 11 women; Mini-Mental State Examination [MMSE] 28.3 ± 1.4) received escalating doses of rivastigmine for 12 weeks in an open-label, pilot study. They were assessed before and after treatment (week 0 and week 12), and after a 4-week washout period (week 16). Assessments included the Mindstreams computerized neuropsychological battery, Activities-specific Balance Confidence Scale, State-Trait Anxiety Inventory, Geriatric Depression Scale, Timed Up and Go (TUG) test, gait speed and stride time variability. One-way multiple analysis of variance tests for repeated measures were used, and Pillai’s trace test was considered as robust to investigate significant differences.
Results
The mean dose of rivastigmine during the 8–12 week period was 5.1 ± 2.3 mg/day. A positive effect was observed on the Mindstreams memory subscale and anxiety scores [Pillai’s trace: F(6,724) = 0.508, p = 0.010; and F(7,792) = 0.545, p = 0.006, respectively, over the course of the study] as well as on mobility (TUG test) [Pillai’s trace: F(4,863) = 0.448; p = 0.028], whereas gait speed and stride time variability did not change.
Conclusions
The use of relatively low-dose rivastigmine did not affect gait speed and stride time variability; however, the general mobility and anxiety were improved. These preliminary results warrant a larger, randomized, placebo-controlled study. 相似文献
The study describes the outcome results of the first 53 patients with an eating disorder referred to a day hospital program, an innovative group treatment for patients requiring hospital treatment. Among the program's completers, 19 fulfilled criteria for anorexia nervosa (AN), and 35 fulfilled criteria for bulimia nervosa (BN). There was a significant weight gain for the AN patients; 73.6% gained over 1 lb/week during the average 12 weeks of stay in the program. There was a significant decrease in the average number of binges per week in the BN group; a reduction of 75% in binges was present in 88% of patients within the study period, 9 AN and 12 BN patients completed a detailed assessment 1, 3, and 6 months postdischarge; for these patients clinical gains were maintained. Factors related to dropout and outcome, as well as clinical implications, are discussed. 相似文献